PC730 Sigma-AldrichAnti-IDE, N-Terminal (97-273) Rabbit pAb
This Anti-IDE, N-Terminal (97-273) Rabbit pAb is validated for use in ELISA, Immunoblotting, Immunocytochemistry, Immunoprecipitation for the detection of IDE, N-Terminal (97-273).
More>> This Anti-IDE, N-Terminal (97-273) Rabbit pAb is validated for use in ELISA, Immunoblotting, Immunocytochemistry, Immunoprecipitation for the detection of IDE, N-Terminal (97-273). Less<<Synonyms: Anti-Insulin Degrading Enzyme, Anti-BC2
Recommended Products
개요
Replacement Information |
---|
주요 사양표
Species Reactivity | Host | Antibody Type |
---|---|---|
Ht, H, M, R | Rb | Polyclonal Antibody |
가격 및 재고여부
카탈로그 번호 | 재고 정보 | 패킹 | 포장 단위 | 가격(VAT 별도) | 수량 | |
---|---|---|---|---|---|---|
PC730-100ULCN |
|
Plastic ampoule | 100 ul |
|
— |
Description | |
---|---|
Overview | Recognizes the ~115 kDa endogenous and recombinant IDE. |
Catalogue Number | PC730 |
Brand Family | Calbiochem® |
Synonyms | Anti-Insulin Degrading Enzyme, Anti-BC2 |
References | |
---|---|
References | Morelli, L., et al. 2003. J. Biol. Chem. 278, 23221. Kurochkin, I.V. and Goto, S. 1994. FEBS Lett. 345, 33. |
Product Information | |
---|---|
Form | Liquid |
Formulation | Undiluted serum. |
Positive control | Rat or mouse liver cytosol |
Preservative | ≤0.1% sodium azide |
Quality Level | MQ100 |
Physicochemical Information |
---|
Dimensions |
---|
Materials Information |
---|
Toxicological Information |
---|
Safety Information according to GHS |
---|
Safety Information |
---|
Product Usage Statements |
---|
Packaging Information |
---|
Transport Information |
---|
Supplemental Information |
---|
Specifications |
---|
Global Trade Item Number | |
---|---|
카탈로그 번호 | GTIN |
PC730-100ULCN | 04055977207910 |
Documentation
Anti-IDE, N-Terminal (97-273) Rabbit pAb MSDS
타이틀 |
---|
Anti-IDE, N-Terminal (97-273) Rabbit pAb Certificates of Analysis
Title | Lot Number |
---|---|
PC730 |
References
참고문헌 보기 |
---|
Morelli, L., et al. 2003. J. Biol. Chem. 278, 23221. Kurochkin, I.V. and Goto, S. 1994. FEBS Lett. 345, 33. |